IFNA2 and chronic kidney disease: In the anti-viral treatment cohort, we found that the antiviral therapy consisting of IFNα-2b combined with RBV decreased the serum creatinine level and improved both the eGFR and severity of CKD, which is in agreement with other studies in western countries and Japan14.